Navigating the CMS 14-Day Rule in Biomarker Testing
Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video LibraryDrs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.
Related Videos

Local Regional Therapy and Surgery for Melanoma
Dr. Sanjiv Agarwala discusses when and why to utilize local regional therapy versus surgery for melanoma.
Clinical Validation of CancerTYPE ID
Dr. Boccia compares CancerTYPE ID to other gene expression tests and reviews studies validating its accuracy and clinical utility.